# A Randomised, Open-Label, Cross Over Group, Single-Centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-Off Membrane Dialyser Compared With High Flux Dialyser Among Patients With Chronic Haemodialysis

> **NCT04160351** · NA · COMPLETED · sponsor: **Selayang Hospital** · enrollment: 44 (actual)

## Conditions studied

- Hemodialysis-Associated Amyloidosis
- Dialysis Amyloidosis
- Quality of Life

## Interventions

- **DEVICE:** Theranova 400
- **DEVICE:** Elisio-19H

## Key facts

- **NCT ID:** NCT04160351
- **Lead sponsor:** Selayang Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04160351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04160351, "A Randomised, Open-Label, Cross Over Group, Single-Centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-Off Membrane Dialyser Compared With High Flux Dialyser Among Patients With Chronic Haemodialysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04160351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*